Pharming Group N.V.

PHAR·NASDAQ·$13.62Share Price as of 11/2·$962MMarket Cap as of 11/2

Financials

20-F/AAnnual report (foreign, amended)04/13/26 20-FAnnual report (foreign)04/02/26 20-FAnnual report (foreign)04/03/25 20-FAnnual report (foreign)04/04/24 20-FAnnual report (foreign)04/05/23

Disclosures

6-KForeign issuer report10/27/26 6-KForeign issuer report10/22/26 6-KForeign issuer report10/14/26 6-KForeign issuer report09/29/26 6-KForeign issuer report09/25/26

Prospectuses and Registrations

S-8Registration of securities for employees10/28/21 424B4Prospectus12/23/20 F-1/ARegistration (foreign issuer, amended)12/22/20 F-1/ARegistration (foreign issuer, amended)12/17/20 F-6Prospectus / registration12/17/20

Proxies

No matching filings.

Ownership

SC 13G/ABeneficial ownership (amended)04/07/25 SC 13G/ABeneficial ownership (amended)11/14/24 SC 13GBeneficial ownership11/08/24 SC 13GBeneficial ownership02/14/24

Other

CERTCEO/CFO certification12/22/20 CORRESPCorrespondence with the SEC12/22/20 CORRESPCorrespondence with the SEC12/22/20 EFFECTRequest for effectiveness12/22/20 EFFECTRequest for effectiveness12/22/20